mesdopetam   Click here for help

GtoPdb Ligand ID: 10811

Synonyms: IRL790
Compound class: Synthetic organic
Comment: Mesdopetam (IRL790) is an experimental small molecule compound with psychomotor stabilizing properties. The primary target is the dopamine D3 receptor, a target implicated in the generation of levodopa-induced dyskinesia, a side-effect frequently occurring with long-term levodopa treatment in patients with Parkinson's disease.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 1
Rotatable bonds 7
Topological polar surface area 63.78
Molecular weight 275.1
XLogP 2.01
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCCNCCOc1cc(F)cc(c1)S(=O)(=O)C
Isomeric SMILES CCCNCCOc1cc(F)cc(c1)S(=O)(=O)C
InChI InChI=1S/C12H18FNO3S/c1-3-4-14-5-6-17-11-7-10(13)8-12(9-11)18(2,15)16/h7-9,14H,3-6H2,1-2H3
InChI Key OSBPYFBXSLJHCR-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
Mesdopetam (IRL790) is an experimental small molecule compound with psychomotor stabilizing properties. The primary target is the dopamine D3 receptor, a target implicated in the generation of levodopa-induced dyskinesia, a side-effect frequently occurring with long-term levodopa treatment in patients with Parkinson's disease.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT03368170 Efficacy and Tolerability of IRL790 in Parkinson's Disease Dyskinesia Phase 2 Interventional Integrative Research Laboratories AB